ERBB2 and inflammatory breast carcinoma: However, hormone receptors (HR) and human epidermal growth factor receptor-2 (HER2), which define the molecular status of IBC according to immunohistochemistry (IHC), are the fundamental markers that are used to demonstrate molecular features, predict the prognosis and optimize therapeutic regimens.